Pharma & Biotech Smith & Nephew tumbles after cutting sales outlook on weak US hips and knees - UPDATE By Oliver Haill 04/08
Pharma & Biotech Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb By Ian Lyall 03/08
Pharma & Biotech genedrive shares rise 9% as UK guideline backs its hearing loss test By Ian Lyall 03/08
Pharma & Biotech Coiled doses first patient on reformulated cancer drug ahead of expansion By Ian Lyall 03/08
Pharma & Biotech Genflow wins fast-track US examination for foundational longevity patent By Ian Lyall 03/08
Pharma & Biotech CelLBxHealth study detects drug targets on cancer cells rivals would miss - UPDATE By Ian Lyall 03/08
Pharma & Biotech Futura Medical gets greenlight for stronger product "Eroxon Intense" By Jamie Ashcroft 31/07
Medical technology & services Imaging Biometrics calls first-half profit a 'decisive first step' By Oliver Haill 29/07
Pharma & Biotech Allergy Therapeutics reports accelerated revenue growth in its second half By Jamie Ashcroft 29/07
Pharma & Biotech AstraZeneca's drug pipeine is splitting opinion among City analysts By Jamie Ashcroft 28/07
Pharma & Biotech GSK hits three-month high as vaccines help earnings top forecasts By Oliver Haill 28/07
Pharma & Biotech Allergy Therapeutics names Helge Weiner-Trapness as executive chair By Jamie Ashcroft 28/07
Pharma & Biotech Faron Pharmaceuticals shares strengthen on upbeat new cancer trial data By Jamie Ashcroft 27/07
Pharma & Biotech AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure - UPDATE By Oliver Haill 27/07
Pharma & Biotech Scancell sees high demand in retail share offer, seals £15.7m from UK investors By Jamie Ashcroft 27/07
